KTP laser versus transurethral resection: Early results of a randomized trial

Journal of Endourology

Volumn 20, Issue 8, 2006, Pages 580-585

  Bouchier Hayes, David M ^a   Anderson, Paul ^a   Van Appledorn, Scott ^a   Bugeja, Pat ^a   Costello, Anthony J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLADDER CATHETERIZATION; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FLOW RATE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LASER SURGERY; LAVAGE; MAJOR CLINICAL STUDY; MALE; MICTURITION; OPERATION DURATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESIDUAL VOLUME; SEXUAL FUNCTION; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC HYPERPLASIA; TRANSURETHRAL RESECTION OF PROSTATE; URINATION DISORDERS;

EID: 33750626721     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2006.20.580     Document Type: Article

References (13)

1. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia: The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995;332:75-79.
2. Brawer MK, McConnell JD, Oesterling JE. What will replace TURP? Contemp Urol 1992;4(2):30-40.
3. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC, Writing Committee, the American Urological Association. Transurethral prostatectomy: Immediate and postoperative complications: Cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-247.
4. Costello AJ, Bowsher WG, Bolton DM, Braslis KG, Burt J. Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 1992;69:603-608.
5. Tan AH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, Fraundorfer MR. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 2003;170:1270-1274.
6. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 1997;49:703-708.
7. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. Potassium-titanyl- phosphate laser vaporization of the prostate: A comparative functional and pathologic study in canines. Urology 1996;48:575-583.
8. Jacques SL. Laser-tissue interactions: Photochemical, photothermal, and photomechanical. Surg Clin North Am 1992;72:531-558.
9. Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003;17:93-96.
10. Roehrborn CG, McConnell JD, Barry MJ, et al. Guidelines on the Management of Benign Prostatic Hyperplasia. Linthicum, MD: American Urological Association, 2003, Chapter 4, appendix 4.
11. Das A, Kennett K, Fraundorfer M, Gilling, P. Holmium laser resection of the prostate (HoLRP): 2-year follow-up data. Techn Urol 2001;7:252-255.
12. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl- phosphate laser vaporization of the benign obstructive prostate: Observations on long-term outcomes. J Urol 2005;174:1344-1348.
13. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, Malek RS. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004;172:1404-1408.